New miRNA Signature for Thyroid Nodule Management
Author Information
Author(s): Quiriny Marie, Rodrigues Vitόria Joel, Saiselet Manuel, Dom Geneviève, De Saint Aubain Nicolas, Willemse Esther, Digonnet Antoine, Dequanter Didier, Rodriguez Alexandra, Andry Guy, Detours Vincent, Maenhaut Carine
Primary Institution: Institut Jules Bordet, Université libre de Bruxelles
Hypothesis
Can a new molecular signature based on miRNA expressions and mutations improve the screening of malignant thyroid nodules?
Conclusion
The study identifies a molecular classifier that effectively distinguishes malignant thyroid nodules with high predictive values.
Supporting Evidence
- The classifier achieved a sensitivity of 76% and specificity of 96%.
- Positive and negative predictive values were both 90% at a disease prevalence of 30%.
- The random forest algorithm was identified as the best classification method.
- The study included all Bethesda categories for comprehensive analysis.
- miRNA expressions were found to be reliable first-line diagnostic markers.
Takeaway
Researchers created a new test that helps doctors tell if thyroid lumps are cancerous, which can help avoid unnecessary surgeries.
Methodology
This prospective non-interventional study analyzed miRNA expressions and mutations in thyroid nodules using fine-needle aspiration biopsy samples.
Potential Biases
Potential biases may arise from the exclusion of certain nodules and the reliance on preoperative FNAB samples.
Limitations
The study did not evaluate the signature on suspicious micronodules smaller than 1 cm and included all Bethesda classifications, which may affect the results.
Participant Demographics
The cohort consisted of 75% women with a median age of 52 years.
Statistical Information
P-Value
0.05
Confidence Interval
90%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website